Dr. Ashif K. Jethava, MD

Dr. Jethava practices at Midlothian Dialysis in Richmond, Virginia.

Dr. Jethava's NPI, 1669632782, was assigned on June 12, 2008. Dr. Jethava holds Virginia license 0101264655.

Dr. Jethava's primary practice is Midlothian Dialysis, at 671 Hioaks Rd, Richmond, VA 23225 in Richmond City. The practice phone is (804) 594-3520.

Dr. Jethava's primary practice is Midlothian Dialysis in Richmond, Virginia. Dr. Jethava is also affiliated with Bon Secours St. Mary's Hospital. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Jethava to 5 more hospitals, 5 medical groups, 2 dialysis centers and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jethava practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Jethava's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Jethava's licenses on file in 3 states: Virginia, Connecticut and Massachusetts.

CMS data shows 3,127 Medicare services from Dr. Jethava across 16 procedure codes in 2024, for 741 Medicare patients. Medicare paid $254,691 for them.

CMS counts 741 Medicare patients who saw Dr. Jethava in 2024. The largest group is 75 to 84, with 316 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jethava's median patient age at 73, with 51% women.

In 2024, Dr. Jethava wrote 2,222 Medicare Part D claims for 418 patients. 84% of them were for generic drugs. CMS names the drug for 1,948 of them, across 36 drugs with 11 or more claims each, at $281,448 in total drug cost. In 2023, CMS named 1,188 claims across 29 drugs.

Dr. Jethava accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Jethava, published from 2013 to 2015. 2013 was the busiest year, with 2. The most frequent topics are Lung Neoplasms. Dr. Jethava has published most often in Conn Med. Dr. Jethava's most frequent co-authors are Constantin Dasanu, MD, PhD, Tapas Bandyopadhyay, MD and Alexei Shimanovsky, MD.

CMS Open Payments shows 165 general payments to Dr. Jethava from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $547.